News Formal

Johnson & Johnson Fourth-Quarter Earnings Down 25%

  • 📰 WSJhealth
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 53%

Business News News

Business Business Latest News,Business Business Headlines

The healthcare-products company reported declining sales in the fourth quarter as demand dropped for its Covid-19 vaccine.

Johnson & Johnson reported a 25% drop in earnings and declining sales for the fourth quarter as demand dropped for its Covid-19 vaccine, while providing a cautious forecast for sales growth as the company undergoes a big transformation.

The New Brunswick, N.J., healthcare-products company said Tuesday that quarterly revenue fell 4.4% to $23.71 billion on fewer vaccine sales and a stronger dollar, below analyst estimates of $23.9 billion, according to FactSet.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 413. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Microsoft Earnings Likely Slid Last Quarter Amid Economic ConcernsThe software giant likely recorded its slowest sales growth in more than six years last quarter as economic concerns cooled demand for its software and cloud services. That's because they did what was once thought impossible, they released a Windows that was worse than Windows 8. 😬😬😬
Source: WSJ - 🏆 98. / 63 Read more »